Industry Relations Council
The AAHPM Industry Relations Council was formed in 2009. The AAHPM IRC hopes to
- build positive relationships and foster dialogue
- gain greater understanding of mutual areas of interest
- further programs that benefit patients and their families.
Participation is available to organizations that support the goals and mission of AAHPM. Annual dues for participation in AAHPM's Industry Relations Council are $7,500.
View our Industry Relations Council brochure for more information and access the application form.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of Autoimmunity, Neuroscience and Infection. AstraZeneca operates over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.
INSYS Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems for therapeutic molecules that improve the quality of patients' lives. Using proprietary sublingual spray technology and our capabilities to develop pharmaceutical cannabinoids, we work to address the clinical shortcomings of existing pharmaceutical products. For more information, please visit https://www.insysrx.com/.